|
Santiago A.R., Aires I.D., Agudo-Barriuso M., Boia R. Editorial: Molecular and cellular players of axonal regeneration in injured CNS. Frontiers in Neuroscience. 2023. 17. 10.3389/fnins.2023.1315632
AÑO: 2023; IF: 3.2
|
|
Norte-Muñoz M., Botelho M.F., Schoeberlein A., Chaves J., Neto Murta J., Ponsaerts P., Agudo-Barriuso M., Costa E. Insights and future directions for the application of perinatal derivatives in eye diseases: A critical review of preclinical and clinical studies. Frontiers in Bioengineering and Biotechnology. 8 November 2022. 10. 10.3389/fbioe.2022.969927
AÑO: 2022; IF: 5.7
|
|
Boia R., Dias P.A.N., Galindo-Romero C., Ferreira H., Aires I.D., Vidal-Sanz M., Agudo-Barriuso M., Bernardes R., Santos P.F., de Sousa H.C., Ambrósio A.F., Braga M.E.M., Santiago A.R. Intraocular implants loaded with A<inf>3</inf>R agonist rescue retinal ganglion cells from ischemic damage. Journal of Controlled Release. March 2022. 343:469-481. 10.1016/j.jconrel.2022.02.001
AÑO: 2022; IF: 10.8
|
|
Boia R., Salinas-Navarro M., Gallego-Ortega A., Galindo-Romero C., Aires I.D., Agudo-Barriuso M., Ambrósio A.F., Vidal-Sanz M., Santiago A.R. Activation of adenosine A<inf>3</inf> receptor protects retinal ganglion cells from degeneration induced by ocular hypertension. Cell Death and Disease. 1 May 2020. 11. 10.1038/s41419-020-2593-y
AÑO: 2020; IF: 8.469
|
|
Boia R., Dias P.A.N., Martins J.M., Galindo-Romero C., Aires I.D., Vidal-Sanz M., Agudo-Barriuso M., de Sousa H.C., Ambrósio A.F., Braga M.E.M., Santiago A.R. Porous poly(ε-caprolactone) implants: A novel strategy for efficient intraocular drug delivery. Journal of Controlled Release. 28 December 2019. 316:331-348. 10.1016/j.jconrel.2019.09.023
AÑO: 2019; IF: 7.727
|